Achondroplasia Treatment Market
According to Intent Market Research, the Achondroplasia Treatment Market is expected to grow from USD 0.03 million in 2023 at a CAGR of 59.8% to touch USD 0.8 million by 2030. The Achondroplasia Treatment Market is dominated by key players such as BioMarin Pharmaceutical, Eli Lilly and Company, Genetics Pharmaceuticals, Pfizer Inc., Novartis AG and Swedish Orphan Biovitrum.